文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Molecular targets of phytochemicals for cancer prevention
侵权投诉

Molecular targets of phytochemicals for cancer prevention

PersPectives

the starting point is a known oncoprotein or a phytochemical with proven anticancer activity (FIG. 1). The first is a target-based approach beginning with target protein

selection on the basis of data ideally obtained from an RNA interference (RNAi) screen (reviewed in REFs 27–29), as well as in vitro, ex vivo and in vivo models. Potential phyto-Ki Won Lee, Ann M. Bode and Zigang Dongchemical candidates can then be selected by

in silico virtual screening, based on natural

Abstract | Although successful for a limited number of tumour types, the efficacy chemical libraries30. An in silico screen

of cancer therapies, especially for late-stage disease, remains poor overall. Many requires diverse ligand databases, such as the have argued that this could be avoided by focusing on cancer prevention, which (see Further information)31, has now entered the arena of targeted therapies. During the process of identifying which contains ‘ready-to-dock’ searchable preventive agents, dietary phytochemicals, which are thought to be safe for human libraries of 4.6 million three-dimensional

compounds ranging from hit-to-lead can-use, have emerged as modulators of key cellular signalling pathways. The task now didates to FDA-approved compounds with is to understand how these chemicals perturb these pathways by modelling their vendor links to order31. The interactions with their target proteins.(see Further information) is another exten-sive library of searchable natural compounds Despite the intensive efforts and substantial signalling. We also address the progress, that are also available for purchase.advances that have occurred through focus-limitations and future directions in target-The X-ray crystallographic structures of

ing on improving treatments, cancer is still driven phytochemical cancer prevention a protein of interest either alone or bound a leading cause of death worldwide. Since research.to an inhibitor or ligand are crucial in the idea of cancer chemoprevention was the process of identifying protein–small

12

introduced by Sporn and Wattenberg et al., Phytochemical-derived anticancer drugsmolecule interactions and designing more the hope for overcoming cancer has started The effort to develop anticancer drugs specific inhibitors. Protein crystal structures to change from one of treatment to one of began in the 1950s. In 1955, the US National that have been resolved are deposited in prevention. The World Health Organization Cancer Institute (NCI) established the the Research Collaboratory for Structural (WHO) indicates that one-third of all cancer Cancer Chemotherapy National Service Bioinformatics (RCSB) protein data bank deaths are preventable and that diet is closely Center to screen natural and synthetic com-(; see Further information)32. However,

linked to cancer prevention (see REF. 3 for pounds that effectively induced cancer cell if a protein crystal structure with a resolu-14a review). On the basis of this idea, and death. One of the most successful FDA-tion average of about 2.0 Å does not exist, numerous epidemiological findings, atten-approved drugs to come from this initiative or the structure has not been resolved,

15

tion has centred on dietary phytochemicals is paclitaxel (Taxol; Bristol-Myers Squibb), homology modelling methods are used to as an effective intervention in cancer devel-which was isolated from the bark of the create a suitable structure with which to

opment. However, the failure of large-scale Pacific Yew tree. Examples of FDA-approved work. Homology modelling between pro-clinical trials in the 1990s, including the anticancer therapeutic agents derived from teins requires that they possess a minimum

4

Alpha-Tocopherol, Beta-Carotene trial and phytochemicals and their identified mecha-protein sequence identity of 30%33, and the the Carotene and Retinol Efficacy Trial5, nisms of action are listed in European Molecular Biology Laboratory-has raised doubts that diet-based cancer (table). These data show European Bioinformatics Institute (prevention can be clinically successful. that phytochemicals with precisely defined ) web service (see Further information) Because these trials were not designed on mechanisms of action based on molecular provides many of the tools necessary for mechanism-based preclinical studies, iden-target identification can be linked to protein sequence searching and align-tifying cancer preventive dietary agents that successful drug discovery.ments34. In addition, the have specific molecular or cellular targets is Phytochemicals, such as resveratrol16–18, (see Further

19–21

thought to be an essential way forwards.(–)-epigallocatechin gallate (EGCG), information) provides databases on protein

22,2324–26

Similar to the development of cancer [6]-gingerol and myricetin, have structures and sequences.therapeutic drugs, the development of recent been reported to directly modulate various A second approach is a compound-based cancer preventive agents is based on the molecular signal transduction pathways, and method that begins with the selection of discovery of precise molecular targets (see research efforts have centred on the effects of putative cancer preventive phytochemical REF. 6 for a review). Because of their success phytochemicals on signalling cascades that candidates based on previous research stud-7–9in clinical trials, drugs such as tamoxifen are known to induce cancer cell death or to ies. From the selected compounds, the most

10–13

and finasteride, which have specific inhibit cancer cell proliferation. However, effective candidates are taken forwards as molecular targets, have been approved by the the specific molecular and cellular targets lead compounds using screening methods US Food and Drug Administration (FDA) need to be identified.such as cell transformation, cell proliferation as cancer preventive agents. In this Opinion and kinase or reporter gene assays. After article, we discuss phytochemical-derived Target discovery methodsselecting lead compounds, candidate target drug discovery and mechanisms by which The overall strategy for discovering molecu-proteins that directly interact with the lead these compounds can modulate distinct tar-lar targets of phytochemicals can involve compounds are identified by ‘reverse dock-get proteins that are involved in oncogenic several approaches depending on whether ing’ on known protein crystal structures

OPiniOn

Molecular targets of phytochemicals

for cancer prevention

CanCer

© 2011 Macmillan Publishers Limited. All rights reserved

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email